Form 8-K - Current report:
SEC Accession No. 0001157523-20-000024
Filing Date
2020-01-06
Accepted
2020-01-06 17:04:26
Documents
2
Period of Report
2020-01-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANIKA THERAPEUTICS, INC. 8-K a52154137.htm 8-K 22841
2 EXHIBIT 99.1 a52154137_ex991.htm EX-99.1 15912
  Complete submission text file 0001157523-20-000024.txt   40014
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 20510717
SIC: 3841 Surgical & Medical Instruments & Apparatus